PCM
KURA icon

Polymer Capital Management’s Kura Oncology KURA Stock Holding History

Polymer Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-31,919
Closed -$332K – 921
2025
Q4 		$332K Sell
31,919
-2,193
-6% -$23K 0.03% 618
2025
Q3 		$302K Sell
34,112
-14,197
-29% -$101K 0.03% 613
2025
Q2 		$279K Sell
48,309
-1,220
-2% -$7.47K 0.03% 445
2025
Q1 		$327K Buy
+49,529
New +$386K 0.08% 342

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Polymer Capital Management's KURA Position: Q1 2026 in Review

Polymer Capital Management sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 31,919 shares — an estimated $332K sold.

Polymer Capital Management first reported a position in KURA in Q1 2025 and held it in 4 quarters. The position peaked at $332K in Q4 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Polymer Capital Management reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Polymer Capital Management sold 31,919 Kura Oncology shares in Q1 2026, an estimated $332K.
  • Polymer Capital Management first reported a position in Kura Oncology in Q1 2025 and held it in 4 quarters.
  • Polymer Capital Management's Kura Oncology position peaked at $332K in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.